P203 Development Of An Optimal F/hn Pseudotyped Siv Vector For Cf Gene Therapy (2014)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2014-206260.332
Publication URI: http://www.abstracts2view.com/asgct/view.php?nu=ASGCT14L1_372
Type: Journal Article/Review
Parent Publication: Thorax
Issue: Suppl 2